Randomized Cross-Over Trial of Insulin Glargine Plus Lispro or NPH Insulin Plus Regular Human Insulin in Adolescents With Type 1 Diabetes on Intensive Insulin Regimens

N. P. Murphy; S. M. Keane; K. K. Ong; M. Ford-Adams; J. A. Edge; C. L. Acerini; D. B. Dunger

doi:10.2337/diacare.26.3.799

Randomized Cross-Over Trial of Insulin Glargine Plus Lispro or NPH Insulin Plus Regular Human Insulin in Adolescents With Type 1 Diabetes on Intensive Insulin Regimens

Diabetes Care ◽

10.2337/diacare.26.3.799 ◽

2003 ◽

Vol 26 (3) ◽

pp. 799-804 ◽

Cited By ~ 114

Author(s):

N. P. Murphy ◽

S. M. Keane ◽

K. K. Ong ◽

M. Ford-Adams ◽

J. A. Edge ◽

...

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Human Insulin ◽

Regular Human Insulin ◽

Nph Insulin

Download Full-text

Treatment Satisfaction and Quality of Life With Insulin Glargine Plus Insulin Lispro Compared With NPH Insulin Plus Unmodified Human Insulin in Individuals With Type 1 Diabetes

Diabetes Care ◽

10.2337/dc07-1183 ◽

2008 ◽

Vol 31 (6) ◽

pp. 1112-1117 ◽

Cited By ~ 45

Author(s):

S. G. Ashwell ◽

C. Bradley ◽

J. W. Stephens ◽

E. Witthaus ◽

P. D. Home

Keyword(s):

Quality Of Life ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Human Insulin ◽

Insulin Lispro ◽

Treatment Satisfaction ◽

Nph Insulin

Download Full-text

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes

Diabetologia ◽

10.1007/s00125-004-1365-z ◽

2004 ◽

Vol 47 (4) ◽

pp. 622-629 ◽

Cited By ~ 253

Author(s):

K. Hermansen ◽

P. Fontaine ◽

K. K. Kukolja ◽

V. Peterkova ◽

G. Leth ◽

...

Keyword(s):

Type 1 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Insulin Detemir ◽

Insulin Analogues ◽

Regular Human Insulin ◽

Nph Insulin ◽

Basal Bolus

Download Full-text

OPTIMIZED BASAL-BOLUS INSULIN REGIMENS IN TYPE 1 DIABETES: INSULIN GLULISINE VERSUS REGULAR HUMAN INSULIN IN COMBINATION WITH BASAL INSULIN GLARGINE

Endocrine Practice ◽

10.4158/ep.11.1.11 ◽

2005 ◽

Vol 11 (1) ◽

pp. 11-17 ◽

Cited By ~ 70

Author(s):

Satish K. Garg ◽

Julio Rosenstock ◽

Kirk Ways

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Human Insulin ◽

Basal Insulin ◽

Regular Human Insulin ◽

Bolus Insulin ◽

Insulin Glulisine ◽

Basal Bolus

Download Full-text

Incidence of severe nocturnal hypoglycemia in patients with type 1 diabetes treated with insulin lispro or regular human insulin in addition to basal insulin glargine

Nutrition Metabolism and Cardiovascular Diseases ◽

10.1016/j.numecd.2009.05.007 ◽

2010 ◽

Vol 20 (7) ◽

pp. 519-526 ◽

Cited By ~ 9

Author(s):

P. Brunetti ◽

M. Muggeo ◽

L. Cattin ◽

A. Arcangeli ◽

P. Pozzilli ◽

...

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Human Insulin ◽

Insulin Lispro ◽

Basal Insulin ◽

Regular Human Insulin ◽

Nocturnal Hypoglycemia

Download Full-text

How do short-acting insulin analogs compare with regular human insulin in adults with type 1 diabetes mellitus?

Cochrane Clinical Answers ◽

10.1002/cca.1466 ◽

2016 ◽

Author(s):

Jane Burch ◽

Eric Wexler

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Human Insulin ◽

Regular Human Insulin ◽

Insulin Analogs ◽

Short Acting ◽

Acting Insulin ◽

Short Acting Insulin

Download Full-text

PDB7 THE RELATIVE COST EFFECTIVENESS OF INSULIN GLARGINE VERSUS NPH INSULIN IN THE UK IN PEOPLE WITH TYPE 1 DIABETES

Value in Health ◽

10.1016/s1098-3015(10)63277-9 ◽

2006 ◽

Vol 9 (6) ◽

pp. A225-A226

Author(s):

P McEwan ◽

CD Poole ◽

P Holmes ◽

AP Tetlow ◽

CJ Currie

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Relative Cost ◽

Nph Insulin ◽

Relative Cost Effectiveness ◽

The Uk

Download Full-text

Microneedle-Based Intradermal Versus Subcutaneous Administration of Regular Human Insulin or Insulin Lispro: Pharmacokinetics and Postprandial Glycemic Excursions in Patients with Type 1 Diabetes

Diabetes Technology & Therapeutics ◽

10.1089/dia.2010.0183 ◽

2011 ◽

Vol 13 (4) ◽

pp. 443-450 ◽

Cited By ~ 40

Author(s):

Ronald J. Pettis ◽

Laurence Hirsch ◽

Christoph Kapitza ◽

Leszek Nosek ◽

Ulrike Hövelmann ◽

...

Keyword(s):

Type 1 Diabetes ◽

Human Insulin ◽

Insulin Lispro ◽

Subcutaneous Administration ◽

Regular Human Insulin

Download Full-text

Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group

Diabetes Care ◽

10.2337/diacare.23.8.1137 ◽

2000 ◽

Vol 23 (8) ◽

pp. 1137-1142 ◽

Cited By ~ 142

Author(s):

J. Rosenstock ◽

G. Park ◽

J. Zimmerman

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Basal Insulin ◽

Nph Insulin ◽

Daily Insulin

Download Full-text

Health economic evaluation of insulin glargine vs NPH insulin in intensified conventional therapy for type 1 diabetes in Germany

Journal of Medical Economics ◽

10.3111/13696998.2012.713879 ◽

2012 ◽

Vol 15 (sup2) ◽

pp. 14-27 ◽

Cited By ~ 11

Author(s):

Martin Pfohl ◽

Peter K. Schädlich ◽

Franz-Werner Dippel ◽

Katharina C. Koltermann

Keyword(s):

Health Economic ◽

Type 1 Diabetes ◽

Economic Evaluation ◽

Insulin Glargine ◽

Conventional Therapy ◽

Health Economic Evaluation ◽

Nph Insulin

Download Full-text

Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 diabetes in the UK

Current Medical Research and Opinion ◽

10.1185/030079906x167561 ◽

2007 ◽

Vol 23 (1) ◽

pp. 7-19 ◽

Cited By ~ 10

Author(s):

Phil McEwan ◽

Chris D. Poole ◽

Tony Tetlow ◽

Paul Holmes ◽

Craig J. Currie

Keyword(s):

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Nph Insulin ◽

The Uk ◽

The Cost

Download Full-text